241 related articles for article (PubMed ID: 16310293)
1. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection.
Antonis AF; Claassen EA; Hensen EJ; de Groot RJ; de Groot-Mijnes JD; Schrijver RS; van der Most RG
Vaccine; 2006 Mar; 24(10):1551-61. PubMed ID: 16310293
[TBL] [Abstract][Full Text] [Related]
2. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
Mapletoft JW; Oumouna M; Townsend HG; Gomis S; Babiuk LA; van Drunen Littel-van den Hurk S
Virology; 2006 Sep; 353(2):316-23. PubMed ID: 16828832
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
[TBL] [Abstract][Full Text] [Related]
5. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
[TBL] [Abstract][Full Text] [Related]
6. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
Oumouna M; Mapletoft JW; Karvonen BC; Babiuk LA; van Drunen Littel-van den Hurk S
J Virol; 2005 Feb; 79(4):2024-32. PubMed ID: 15681404
[TBL] [Abstract][Full Text] [Related]
7. Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves.
Kalina WV; Woolums AR; Gershwin LJ
Vaccine; 2005 Aug; 23(37):4625-30. PubMed ID: 15967545
[TBL] [Abstract][Full Text] [Related]
8. Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses.
Berghaus LJ; Corbeil LB; Berghaus RD; Kalina WV; Kimball RA; Gershwin LJ
Vaccine; 2006 Aug; 24(33-34):6018-27. PubMed ID: 16777273
[TBL] [Abstract][Full Text] [Related]
9. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
Platt R; Burdett W; Roth JA
Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
[TBL] [Abstract][Full Text] [Related]
10. Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus.
Werling D; Collins RA; Taylor G; Howard CJ
J Leukoc Biol; 2002 Aug; 72(2):297-304. PubMed ID: 12149420
[TBL] [Abstract][Full Text] [Related]
11. Bovine respiratory syncytial virus-specific immune responses in calves after inoculation with commercially available vaccines.
Ellis JA; Hassard LE; Morley PS
J Am Vet Med Assoc; 1995 Feb; 206(3):354-61. PubMed ID: 7751246
[TBL] [Abstract][Full Text] [Related]
12. Effects of perinatal vaccination on humoral and cellular immune responses in cows and young calves.
Ellis JA; Hassard LE; Cortese VS; Morley PS
J Am Vet Med Assoc; 1996 Feb; 208(3):393-400. PubMed ID: 8575972
[TBL] [Abstract][Full Text] [Related]
13. Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production.
Kalina WV; Anderson ML; Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):138-56. PubMed ID: 16644011
[TBL] [Abstract][Full Text] [Related]
14. Immunology of bovine respiratory syncytial virus infection of cattle.
Gershwin LJ
Comp Immunol Microbiol Infect Dis; 2012 May; 35(3):253-7. PubMed ID: 22410266
[TBL] [Abstract][Full Text] [Related]
15. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
Ellis JA; Gow SP; Goji N
J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
[TBL] [Abstract][Full Text] [Related]
16. [Immunobiology of bovine respiratory syncytial virus infections].
Schrijver RS
Tijdschr Diergeneeskd; 1998 Nov; 123(22):658-62. PubMed ID: 9836385
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.
Hamers C; Juillard V; Fischer L
J Comp Pathol; 2007 Jul; 137 Suppl 1():S35-41. PubMed ID: 17553517
[TBL] [Abstract][Full Text] [Related]
18. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
[TBL] [Abstract][Full Text] [Related]
20. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
